Researchers have discovered that blood signatures of cell type-specific aging can forecast disease risk and resilience, according to a study published in Nature Medicine on June 15, 2026.
A new randomized crossover study published in Nature Medicine on June 15, 2026, shows that adaptive deep brain stimulation is feasible and safe for dynamic gait control in Parkinson's disease patients.
The World Health Organization (WHO) has agreed to let the cruise ship MV Hondius dock off Tenerife, in the Canary Islands, after an apparent outbreak of person-to-person spread hantavirus infections on board.
Italian pharma company Angelini Pharma has acquired Catalyst Pharmaceuticals, a Florida-based rare-disease focused firm, for roughly $4.1 billion in cash.
Roche plans to acquire digital pathology firm PathAI in a deal potentially worth over $1 billion, with the goal of improving cancer diagnosis and tailored treatment.
The development and deployment of artificial intelligence in healthcare has been hailed as a game-changer, promising to streamline administrative tasks and improve patient outcomes.